Acro Biomedical (ACBM) Retained Earnings (2015 - 2025)

Acro Biomedical's Retained Earnings history runs 11 years deep, the most recent figure standing at -$32.8 million for Q4 2025.

• In Q4 2025, Retained Earnings changed 0.31% year-over-year to -$32.8 million; the TTM figure through Dec 2025 stood at -$32.8 million (changed 0.31% YoY), while the FY2025 annual figure was -$32.8 million, changed 0.31% from the prior year.
• Retained Earnings was -$32.8 million for Q4 2025 at Acro Biomedical, roughly flat from -$32.8 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$298148.0 in Q1 2021 to a low of -$32.8 million in Q3 2025.
• Historically, Retained Earnings has averaged -$23.5 million across 5 years, with a median of -$31.8 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Retained Earnings tumbled 3879.66% in 2022, then fell 0.13% in 2025.
• A 5-year view of Retained Earnings shows it stood at -$7.9 million in 2021, then sank by 199.98% to -$23.8 million in 2022, then plunged by 36.99% to -$32.6 million in 2023, then decreased by 0.13% to -$32.7 million in 2024, then declined by 0.31% to -$32.8 million in 2025.
• The last three Retained Earnings figures came in at -$32.8 million (Q4 2025), -$32.8 million (Q3 2025), and -$32.7 million (Q2 2025), per Business Quant data.